Cargando…
Ginsenoside Rb1 does not halt osteoporotic bone loss in ovariectomized rats
Osteoporosis (OP) is a systemic skeletal disorder, manifesting with a reduction in bone mass and deterioration of the microarchitecture. Mesenchymal stem cells (MSCs) have an innate ability to differentiate into several cell types, including osteoblasts (OB). Ginsenoside Rb1 (GRb1) is an ethanol ext...
Autores principales: | Bei, JiaXin, Zhang, XinLe, Wu, JingKai, Hu, ZhuoQing, Xu, BiLian, Lin, Sien, Cui, Liao, Wu, Tie, Zou, LiYi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6136715/ https://www.ncbi.nlm.nih.gov/pubmed/30212470 http://dx.doi.org/10.1371/journal.pone.0202885 |
Ejemplares similares
-
Systemic Administration of Allogeneic Mesenchymal Stem Cells Does Not Halt Osteoporotic Bone Loss in Ovariectomized Rats
por: Huang, Shuo, et al.
Publicado: (2016) -
Correction: Systemic Administration of Allogeneic Mesenchymal Stem Cells Does Not Halt Osteoporotic Bone Loss in Ovariectomized Rats
por: Huang, Shuo, et al.
Publicado: (2017) -
Translational potential of ginsenoside Rb1 in managing progression of osteoarthritis
por: Chen, Yuanfeng, et al.
Publicado: (2016) -
Ginsenoside Rb1 ameliorates cisplatin-induced learning and memory impairments
por: Chen, Chen, et al.
Publicado: (2019) -
Ginsenoside Rb1 improves energy metabolism after spinal cord injury
por: Wen, Shan, et al.
Publicado: (2022)